美国导管导引线市场规模、份额和趋势分析报告：产品和细分市场预测（2025-2033 年）

美国导管导引线市场摘要

2024年美国导管导引线市场规模估计为8.306亿美元，预计2033年将达到12.743亿美元。

预计从 2025 年到 2033 年，该市场将以 4.87% 的复合年增长率成长。泌尿系统疾病、心血管疾病和周边动脉疾病(PAD) 的日益普遍是市场成长的主要驱动因素。

此外，微创手术的兴起以及人口老化加剧，为产品需求的成长提供了机会。冠状动脉和周边血管介入手术的增加以及人口老化等因素正在推动国内对微创手术的需求，预计这将在未来几年对市场产生积极影响。在美国，由于侵入性手术感染风险较高，大多数患者选择非侵入性手术。根据耶鲁大学医学院公布的数据，美国每年约进行90万例经皮冠状动脉介入治疗（PCI）。如此庞大的手术量预计将支撑全国对导管导引线的需求。

此外，旨在拓展导管导引线应用范围的临床试验和研究数量不断增长，预计将显着推动该国市场成长。这些研究日益着重于评估导管导引线在各种手术中的安全性和有效性，并促进新型先进产品的研发。研究机构、学术中心和产业相关人员正积极参与这些研究。积极的临床结果验证了产品的性能，有助于获得监管部门的核准，并提高临床医生的使用率，从而进一步促进市场扩张。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国导管导引线市场变数、趋势与范围

• 市场谱系展望
  • 母市场展望
• 市场动态
• 美国导管导引线市场分析工具
  • 波特分析
  • PESTEL 分析

第四章：美国导管导引线市场：依产品分類的估算与趋势分析

• 美国导管导引线市场产品波动分析
• 美国导管导引线市场规模及趋势分析（依产品分类，2021-2033 年）
• 冠状动脉导管导引线
• 末梢血管导管导引线
• 泌尿系统导管导引线
• 神经血管导管导引线

第五章 竞争情势

• 对主要市场参与企业近期趋势和影响的分析
• 公司/竞争对手分类
  • 创新者
• 供应商概况
  • 主要经销商和通路伙伴
  • Key customers
  • US key company market share analysis, 2024
  • Boston Scientific Corporation
  • Medtronic
  • Cook
  • Terumo Medical Corporation
  • Abbott
  • Stryker
  • Teleflex Incorporated
  • BD
  • ASAHI INTECC USA, INC.
  • Olympus America
  • Dornier MedTech.
  • Koninklijke Philips NV
• 热力图分析/企业市场分析
• 2024年企业市场占有率预测分析
• 其他主要市场参与者名单

U.S. Guidewires Market Summary

The U.S. guidewires market size was estimated at USD 830.6 million in 2024 and is projected to reach USD 1,274.3 million by 2033, growing at a CAGR of 4.87% from 2025 to 2033. The increasing prevalence of urological disorders, cardiovascular diseases, and Peripheral Artery Disease (PAD) is significantly driving the growth of the market.

Moreover, a growing number of minimally invasive surgeries, paired with a rising geriatric population, presents an opportunity for increased product demand. Factors such as a rising number of coronary & peripheral intervention procedures and an increase in the geriatric population are resulting in high demand for minimally invasive surgeries in the country. This is expected to have a positive impact on the market in the years to come. A majority of people in the U.S. are inclined towards noninvasive surgeries owing to the probability of high infection associated with invasive procedures. According to data published by Yale Medicine, approximately 900,000 percutaneous coronary interventions (PCIs) are performed in the U.S. every year. Thus, such a high procedural volume is anticipated to support the nationwide demand for guidewires.

Moreover, the rising number of clinical trials and research studies aimed at expanding the applications of guidewires is expected to significantly support the country's market growth. These trials are increasingly focused on assessing the safety and efficacy of guidewires across various procedures, as well as accelerating the development of novel and advanced products. Research institutions, academic centers, and industry players are actively collaborating on these investigations. Favorable clinical outcomes validate product performance, facilitating regulatory approvals, enhancing clinician adoption, and contributing to broader market expansion.

U.S. Guidewires Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. guidewires market report based on product:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Coronary Guidewires
  • Peripheral Guidewires
  • Urology Guidewires
  • Neurovascular Guidewires

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Guidewires Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increased Prevalence of Chronic Diseases
    • 3.2.1.2. Advancements in Medical Technology
    • 3.2.1.3. Increasing Preference for Minimally Invasive Procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Alternative Treatment Options
    • 3.2.2.2. Stringent Regulatory Requirements
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Supportive Government Initiatives
    • 3.2.3.2. Rising Clinical Studies and Trials
    • 3.2.3.3. Growing Expansion of Healthcare Infrastructure
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Product Recalls
    • 3.2.4.2. Potential Risks And Complications
• 3.3. U.S. Guidewires Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Guidewires Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Guidewires Market Product Movement Analysis
• 4.3. U.S. Guidewires Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Coronary Guidewires
  • 4.4.1. Coronary Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Peripheral Guidewires
  • 4.5.1. Peripheral Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. Urology Guidewires
  • 4.6.1. Urology Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.7. Neurovascular Guidewires
  • 4.7.1. Neurovascular Guidewires market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Recent Developments & Impact Analysis, By Key Market Participants
• 5.2. Company/Competition Categorization
  • 5.2.1. Innovators
• 5.3. Vendor Landscape
  • 5.3.1. List of key distributors and channel partners
  • 5.3.2. Key customers
  • 5.3.3. U.S. key company market share analysis, 2024
  • 5.3.4. Boston Scientific Corporation
    • 5.3.4.1. Company overview
    • 5.3.4.2. Financial performance
    • 5.3.4.3. Product benchmarking
    • 5.3.4.4. Strategic initiatives
  • 5.3.5. Medtronic
    • 5.3.5.1. Company overview
    • 5.3.5.2. Financial performance
    • 5.3.5.3. Product benchmarking
    • 5.3.5.4. Strategic initiatives
  • 5.3.6. Cook
    • 5.3.6.1. Company overview
    • 5.3.6.2. Financial performance
    • 5.3.6.3. Product benchmarking
    • 5.3.6.4. Strategic initiatives
  • 5.3.7. Terumo Medical Corporation
    • 5.3.7.1. Company overview
    • 5.3.7.2. Financial performance
    • 5.3.7.3. Product benchmarking
    • 5.3.7.4. Strategic initiatives
  • 5.3.8. Abbott
    • 5.3.8.1. Company overview
    • 5.3.8.2. Financial performance
    • 5.3.8.3. Product benchmarking
    • 5.3.8.4. Strategic initiatives
  • 5.3.9. Stryker
    • 5.3.9.1. Company overview
    • 5.3.9.2. Financial performance
    • 5.3.9.3. Product benchmarking
    • 5.3.9.4. Strategic initiatives
  • 5.3.10. Teleflex Incorporated
    • 5.3.10.1. Company overview
    • 5.3.10.2. Financial performance
    • 5.3.10.3. Product benchmarking
    • 5.3.10.4. Strategic initiatives
  • 5.3.11. BD
    • 5.3.11.1. Company overview
    • 5.3.11.2. Financial performance
    • 5.3.11.3. Product benchmarking
    • 5.3.11.4. Strategic initiatives
  • 5.3.12. ASAHI INTECC USA, INC.
    • 5.3.12.1. Company overview
    • 5.3.12.2. Financial performance
    • 5.3.12.3. Product benchmarking
    • 5.3.12.4. Strategic initiatives
  • 5.3.13. Olympus America
    • 5.3.13.1. Company overview
    • 5.3.13.2. Financial performance
    • 5.3.13.3. Product benchmarking
    • 5.3.13.4. Strategic initiatives
  • 5.3.14. Dornier MedTech.
    • 5.3.14.1. Company overview
    • 5.3.14.2. Financial performance
    • 5.3.14.3. Product benchmarking
    • 5.3.14.4. Strategic initiatives
  • 5.3.15. Koninklijke Philips N.V.
    • 5.3.15.1. Company overview
    • 5.3.15.2. Financial performance
    • 5.3.15.3. Product benchmarking
    • 5.3.15.4. Strategic initiatives
• 5.4. Heat Map Analysis/ Company Market Position Analysis
• 5.5. Estimated Company Market Share Analysis, 2024
• 5.6. List of Other Key Market Players

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. guidewires market, by product, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Guidewires Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 U.S. Guidewires Market, for Product, 2021 - 2033 (USD Million)
• Fig. 14 U.S. Guidewires Market, for Coronary Guidewires, 2021 - 2033 (USD Million)
• Fig. 15 U.S. Guidewires Market, for Peripheral Guidewires, 2021 - 2033 (USD Million)
• Fig. 16 U.S. Guidewires Market, for Urology Guidewires, 2021 - 2033 (USD Million)
• Fig. 17 U.S. Guidewires Market, for Neurovascular Guidewires, 2021 - 2033 (USD Million)